Cargando…

Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu

SARS-CoV-2 ‘Variants of Concern’ (VOCs) continue to reshape the trajectory of the COVID-19 pandemic. However, why some VOCs, like Omicron, become globally dominant while the spread of others is limited is not fully understood. To address this question, we investigated the VOC Mu, which was first ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrone, Mary E., Lucas, Carolina, Menasche, Bridget, Breban, Mallery I., Yildirim, Inci, Campbell, Melissa, Omer, Saad B., Ko, Albert I., Grubaugh, Nathan D., Iwasak, Akiko, Wilen, Craig B., Vogels, Chantal B.F., Fauver, Joseph R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978943/
https://www.ncbi.nlm.nih.gov/pubmed/35378749
http://dx.doi.org/10.1101/2022.03.28.22273077
_version_ 1784681065312419840
author Petrone, Mary E.
Lucas, Carolina
Menasche, Bridget
Breban, Mallery I.
Yildirim, Inci
Campbell, Melissa
Omer, Saad B.
Ko, Albert I.
Grubaugh, Nathan D.
Iwasak, Akiko
Wilen, Craig B.
Vogels, Chantal B.F.
Fauver, Joseph R.
author_facet Petrone, Mary E.
Lucas, Carolina
Menasche, Bridget
Breban, Mallery I.
Yildirim, Inci
Campbell, Melissa
Omer, Saad B.
Ko, Albert I.
Grubaugh, Nathan D.
Iwasak, Akiko
Wilen, Craig B.
Vogels, Chantal B.F.
Fauver, Joseph R.
author_sort Petrone, Mary E.
collection PubMed
description SARS-CoV-2 ‘Variants of Concern’ (VOCs) continue to reshape the trajectory of the COVID-19 pandemic. However, why some VOCs, like Omicron, become globally dominant while the spread of others is limited is not fully understood. To address this question, we investigated the VOC Mu, which was first identified in Colombia in late 2020. Our study demonstrates that, although Mu is less sensitive to neutralization compared to variants that preceded it, it did not spread significantly outside of South and Central America. Additionally, we find evidence that the response to Mu was impeded by reporting delays and gaps in the global genomic surveillance system. Our findings suggest that immune evasion alone was not sufficient to outcompete highly transmissible variants that were circulating concurrently with Mu. Insights into the complex relationship between genomic and epidemiological characteristics of previous variants should inform our response to variants that are likely to emerge in the future.
format Online
Article
Text
id pubmed-8978943
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-89789432022-04-05 Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu Petrone, Mary E. Lucas, Carolina Menasche, Bridget Breban, Mallery I. Yildirim, Inci Campbell, Melissa Omer, Saad B. Ko, Albert I. Grubaugh, Nathan D. Iwasak, Akiko Wilen, Craig B. Vogels, Chantal B.F. Fauver, Joseph R. medRxiv Article SARS-CoV-2 ‘Variants of Concern’ (VOCs) continue to reshape the trajectory of the COVID-19 pandemic. However, why some VOCs, like Omicron, become globally dominant while the spread of others is limited is not fully understood. To address this question, we investigated the VOC Mu, which was first identified in Colombia in late 2020. Our study demonstrates that, although Mu is less sensitive to neutralization compared to variants that preceded it, it did not spread significantly outside of South and Central America. Additionally, we find evidence that the response to Mu was impeded by reporting delays and gaps in the global genomic surveillance system. Our findings suggest that immune evasion alone was not sufficient to outcompete highly transmissible variants that were circulating concurrently with Mu. Insights into the complex relationship between genomic and epidemiological characteristics of previous variants should inform our response to variants that are likely to emerge in the future. Cold Spring Harbor Laboratory 2022-03-30 /pmc/articles/PMC8978943/ /pubmed/35378749 http://dx.doi.org/10.1101/2022.03.28.22273077 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Petrone, Mary E.
Lucas, Carolina
Menasche, Bridget
Breban, Mallery I.
Yildirim, Inci
Campbell, Melissa
Omer, Saad B.
Ko, Albert I.
Grubaugh, Nathan D.
Iwasak, Akiko
Wilen, Craig B.
Vogels, Chantal B.F.
Fauver, Joseph R.
Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu
title Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu
title_full Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu
title_fullStr Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu
title_full_unstemmed Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu
title_short Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu
title_sort insights into the limited global spread of the immune evasive sars-cov-2 variant mu
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978943/
https://www.ncbi.nlm.nih.gov/pubmed/35378749
http://dx.doi.org/10.1101/2022.03.28.22273077
work_keys_str_mv AT petronemarye insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu
AT lucascarolina insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu
AT menaschebridget insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu
AT brebanmalleryi insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu
AT yildiriminci insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu
AT campbellmelissa insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu
AT omersaadb insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu
AT koalberti insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu
AT grubaughnathand insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu
AT iwasakakiko insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu
AT wilencraigb insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu
AT vogelschantalbf insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu
AT fauverjosephr insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu